Our goal is to understand how the cellular response to growth hormone is initiated and regulated in target cells. The initiating step in hormone action is binding to membrane receptors. Elucidation of the molecular basis of growth hormone action therefore requires the isolation and purification of this receptor. Growth hormone possesses insulin-like and anti-insulin actions. Growth hormone and insulin each increase the phosphorylation of a protein of Mr 46,000. Pre-exposure to growth hormone decreases the number of insulin receptors on hepatocytes. The role of these processes in potentiating the actions of growth hormone will be characterized. Growth hormone action in cells is regulated by the affinity state of the receptor and the number of receptors on the cell surface. We will characterize the mechanisms that mediate the up- and down-regulation of the growth hormone receptor and determine if a relationship exists between receptor affinity state and receptor activity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK030788-06
Application #
3229648
Study Section
Endocrinology Study Section (END)
Project Start
1982-05-01
Project End
1990-04-30
Budget Start
1987-05-01
Budget End
1988-04-30
Support Year
6
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065